feed,title,long_url,short_url
Benzinga,Analysts See Softened Timelines For CRISPR Therapeutics' Sickle Cell Candidate In US,https://benzinga.com/general/biotech/22/08/28423846/analysts-see-softened-timelines-for-crispr-therapeutics-sickle-cell-candidate-in-us,https://bit.ly/3A7rj3Q
